
Deutsche Bank Upgrades DocMorris to 'Buy,' Doubles Price Target to 11.50 Francs
Deutsche Bank upgraded the Swiss online pharmacy to 'Buy' from 'Hold' and raised its price target to 11.50 francs, citing reduced funding risks, a favorable regulatory backdrop, and strong earnings potential.







